Niu, J., Scheuerell, C., Mehrotra, S., Karan, S., Puhalla, S., Kiesel, B. F., . . . Beumer, J. H. (2017). Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients with BRCA 1/2 - Mutated Cancer or PARP Sensitive Tumor Types. J Clin Pharmacol.
Chicago-tyylinen lähdeviittausNiu, Jing, et al. "Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2 - Mutated Cancer or PARP Sensitive Tumor Types." J Clin Pharmacol 2017.
MLA-viiteNiu, Jing, et al. "Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2 - Mutated Cancer or PARP Sensitive Tumor Types." J Clin Pharmacol 2017.